CORC

在结果中检索

CORC

浏览/检索结果: 共20条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Multi-Section Waveguide Method for Facet Temperature Reduction and Improved Reliability of High-Power Laser Diodes 会议论文
Virtual, Online, 2022-05-09
作者:  Ebadi, Kaveh;  Liu, Yuxian;  Sünnetçiolu, Ali Kaan;  Gündodu, Sinan;  Sengül, Serdar
收藏  |  浏览/下载：9/0  |  提交时间：2022/07/28
Research on 940nm kilowatt high efficiency quasi-continuous diode laser bars 会议论文
Shanghai, China, 2019-03-17
作者:  Zhao, Yuliang;  Wang, Zhenfu;  Yang, Guowen;  Li, Te;  Song, Yunfei
收藏  |  浏览/下载：53/0  |  提交时间：2019/08/14
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. 会议论文
作者:  Li, Jin;  Xu, Ruihua;  Bai, Yuxian;  Xu, Jianming;  Liu, Tianshu
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Indirect economic impact assessment of sea ice disasters on industries related in China 会议论文
28th International Ocean and Polar Engineering Conference, 2018, Sapporo, Japan, 2018-06-10
作者:  Liu, Xueqin;  Yuan, Shuai;  Wu, Jidong;  Song, Lina;  Ma, Yuxian
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/02
Safety and tolerability profile of raltitrexed in Chinese patients with locally advanced or recurrent and metastatic colorectal cancer: A phase IV trial. 会议论文
作者:  Qin, Shukui;  Li, Jin;  Liu, Yunpeng;  Chen, Yin;  Xu, Nong
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04
Anlotinib in metastatic renal cell carcinoma (mRCC) with a previous anti-VEGFR TKI: Preliminary results from a multicenter, phase II trial. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Van;  Li, Hangzhong;  Xie, Xiaodong
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. 会议论文
作者:  Qin, Shukui;  Kim, Tae Won;  Yau, Thomas Cheung;  Ma, Brigette;  Pan, Hongming
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer 会议论文
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Keming;  Wu, Gang;  Shi, Chunmei
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace